Drugs / Imiglucerase GZ437843
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03485677 | Apr 2018 → Dec 2025 | Gaucher disease type I, Gaucher disease type III | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Imiglucerase GZ437843 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03485677 ↗ |
| Route | Intravenous | “Route of administration: Intravenous” NCT03485677 ↗ |